Exane Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Exane Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,253	Closed	-$218K	–	37
2019 Q3	$218K	Hold	2,253	–	–	0.17%	25
2019 Q2	$231K	Sell	2,253 -20,605	-90%	-$2.22M	0.1%	49
2019 Q1	$2.6M	Buy	+22,858	New	+$1.68M	1.27%	26

Exane Asset Management's ONCE Position: Q4 2019 in Review

Exane Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 2,253 shares — an estimated $218K sold.

Exane Asset Management first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $2.6M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Exane Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Exane Asset Management sold 2,253 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $218K.
Exane Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Exane Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $2.6M in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Exane Asset Management's 13F filing for Q4 2019, filed 3 Feb 2020.